← Evidence map

ArticleTherapeutic innovation & regulatory science2017

Overview of FDA's Expanded Access Program for Investigational Drugs.

Jonathan P Jarow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

36 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28553565